Related Experiment Video
Updated: Aug 9, 2026

An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET Microscopy and Immunofluorescence
Published on: May 2, 2025
A proteomic approach for dissecting H-Ras signaling networks in NIH/3T3 mouse embryonic fibroblast cells
Jung Wook Park1, Seyoon Kim, Young Yil Bahk
1Department of Biochemistry, College of Science, Yonsei University, Seoul, Korea.
Abstract:
To elucidate an understanding into H-Ras protein network, we have established various oncogene H-Ras-expressing NIH/3T3 mouse embryonic fibroblast cell clones, which are expressing G12V H-Ras, G12R H-Ras, and G12V/T35S H-Ras proteins under the tight control of expression by an antibiotic doxycycline. Here we provide a catalog of proteome profiles in total cell lysate derived from the oncogenic and partial loss of function H-Ras-expressing NIH/3T3 cells. In this biological context, we compared total proteome changes by the combined methods of 2-DE, quantitative image analysis and MALDI-TOF-MS analysis both commonly in oncogenic and partial loss of function H-Ras expression system. Thus, we tried to dissect H-Ras signaling pathway, especially a downstream effector molecule, Raf in NIH/3T3 cells using proteomics tools. In this study, we centralized upon the proteome profile changes as common targets for oncogenic H-Ras and a partial loss of function H-Ras in the H-Ras-expressing cells. Thirteen protein spots were selected as what the staining intensities on the gels for 2-DE images from both kinds of cells were consistently changed in their protein expression level. Differentially regulated expression was further confirmed for some subsets of candidates by semiquantitative RT-PCR and Western blot analysis using specific antibodies. Taken together, our results obtained and present here show that the comparative analysis of proteome from oncogenic and partial loss of function H-Ras-expressing cells has yielded interpretable data to elucidate the protein network directly and/or indirectly.
Insights
This study catalogs proteome changes in NIH/3T3 cells expressing oncogenic H-Ras proteins. Proteomics identified common protein targets for oncogenic and partial loss of function H-Ras, aiding H-Ras signaling pathway elucidation.
Area of Science:
- Molecular Biology
- Proteomics
- Cell Biology
Background:
- The H-Ras protein network is crucial in cell signaling.
- Understanding oncogenic H-Ras function is vital for cancer research.
- NIH/3T3 mouse embryonic fibroblast cells are a standard model for studying cellular transformation.
Purpose of the Study:
- To catalog proteome profiles in NIH/3T3 cells expressing oncogenic and partial loss of function H-Ras proteins.
- To dissect the H-Ras signaling pathway, focusing on downstream effectors like Raf.
- To identify common protein targets affected by both oncogenic and partial loss of function H-Ras.
Main Methods:
- Establishment of doxycycline-inducible H-Ras expressing NIH/3T3 cell clones (G12V, G12R, G12V/T35S).
- Comparative proteomic analysis using 2-DE, quantitative image analysis, and MALDI-TOF-MS.
- Validation of differentially expressed proteins using semiquantitative RT-PCR and Western blot analysis.
Main Results:
- Thirteen protein spots with consistently altered expression levels were identified in both oncogenic and partial loss of function H-Ras systems.
- Differential expression of selected candidate proteins was confirmed through RT-PCR and Western blotting.
- Proteomic data provided insights into the H-Ras protein network and downstream signaling.
Conclusions:
- Comparative proteomic analysis effectively elucidates protein network changes associated with H-Ras.
- The study identified common protein targets regulated by oncogenic and partial loss of function H-Ras.
- Findings contribute to a better understanding of the H-Ras signaling pathway in NIH/3T3 cells.
Related Concept Videos
MAPK Signaling Cascades
The Ras Gene
Ras is a superfamily...
